Zhonglin Hao
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| ChemoRadiation And Tislelizumab for Esophageal/EGJ Cancer (NCT05245760) | Zhonglin Hao | 2022-04-01 |
| Lung Cancer With Copanlisib and Durvalumab (NCT04895579) | Zhonglin Hao | 2021-05-12 |
| Combination Rucaparib With Nivolumab in Small Cell Lung Carcinoma (NCT03958045) | Zhonglin Hao | 2019-09-04 |
Track Zhonglin Hao automatically
Every clearance here is in the API, with alerts when new ones post.